Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.45M
Expense Ratio	0.85%
PE Ratio	42.02
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.62%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	25.31%

Volume	5,869
Open	37.30
Previous Close	37.82
Day's Range	36.92 - 37.30
52-Week Low	31.08
52-Week High	42.41
Beta	1.03
Holdings	37
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

48.72% of assets

Name	Symbol	Weight
Legence Corp.	LGN	5.93%
Kratos Defense & Security Solutions, Inc.	KTOS	5.14%
Insulet Corporation	PODD	5.04%
MasTec, Inc.	MTZ	4.98%
Customers Bancorp, Inc.	CUBI	4.95%
Alphabet Inc.	GOOGL	4.80%
AppLovin Corporation	APP	4.56%
Zscaler, Inc.	ZS	4.54%
Carpenter Technology Corporation	CRS	4.45%
eBay Inc.	EBAY	4.33%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 0.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.09%.